Rupal Bhatt is the Senior Vice President of Science and Translation at Instil Bio, where they lead the development of a VEGF/PDL1 bispecific asset. With nearly two decades of experience at the intersection of academic medicine and the pharmaceutical industry, Rupal has expertise in oncology and translational medicine related to clinical drug development. They previously served as Vice President of Translational Medicine at Bristol Myers Squibb, directing a team that enabled significant advancements for multiple oncology assets. Rupal holds a Bachelor of Arts and a Bachelor of Science in Biochemistry from Harvard University and is pursuing a Doctor of Philosophy in Developmental Neuroscience and an MD from prestigious institutions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices